Vaccine: R21/Matrix-M / CYVAC

Manufacturer

Serum Institute of India / University of Oxford

Vaccine type

Protein subunit / Virus-like particle

First authorization

2023 (Ghana) — source

Information links

https://extranet.who.int/prequal/vaccines/p/cyvac
https://www.who.int/news/item/21-12-2023-who-prequalifies-a-second-malaria-vaccine-a-significant-milestone-in-prevention-of-the-disease

Protects against (1)